Treatment of Crohn's anal fistulas guided by magnetic resonance imaging.

Crohn’s disease anal fistula magnetic resonance imaging

Journal

Przeglad gastroenterologiczny
ISSN: 1895-5770
Titre abrégé: Prz Gastroenterol
Pays: Poland
ID NLM: 101280380

Informations de publication

Date de publication:
2019
Historique:
received: 09 09 2018
accepted: 07 10 2018
entrez: 5 4 2019
pubmed: 5 4 2019
medline: 5 4 2019
Statut: ppublish

Résumé

Clinical evaluation of the Crohn's anal fistulas (CF) closure is inadequate to some extent due to earlier closure of cutaneous openings compared to fistulous tracts. There is a need for a more accurate method of assessment. To compare clinical signs of CF with radiological findings, before and after treatment, to follow complete closure. It was a retrospective study of 23 patients suffering from CF admitted to a single specialist centre, who were treated with a combination of surgical and biological therapy. Fistula healing was evaluated with fistula drainage assessment classification (FDA), perianal disease activity index (PDAI), and van Assche magnetic resonance imaging score (MRI) before and 3 months after surgery and induction of the biological treatment. Clinical response occurred in 13 (57%) patients 3 months after induction treatment. Complete clinical response was achieved in 8 (35%) patients, whereas partial response occurred in 5 (22%) patients. Persistence of a fistula tract was visualised on MRI in 4 (50%) patients with clinical closure. The healing process of CF should be monitored by MRI due to the discrepancy between premature closure of external openings and fistulous tracts. Prolonged biological therapy until complete healing of anal fistulas confirmed on MRI might improve the results of treatment.

Identifiants

pubmed: 30944678
doi: 10.5114/pg.2019.83426
pii: 36009
pmc: PMC6444106
doi:

Types de publication

Journal Article

Langues

eng

Pagination

55-61

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

N Engl J Med. 1999 May 6;340(18):1398-405
pubmed: 10228190
Am J Gastroenterol. 2003 Feb;98(2):332-9
pubmed: 12591051
Br J Surg. 1976 Jan;63(1):1-12
pubmed: 1267867
Gastroenterology. 2005 Apr;128(4):862-9
pubmed: 15825070
Aliment Pharmacol Ther. 2006 Apr 15;23(8):1127-36
pubmed: 16611273
Dig Dis Sci. 2009 Aug;54(8):1746-52
pubmed: 19003531
Gut. 2009 Jul;58(7):940-8
pubmed: 19201775
J Gastrointest Surg. 2009 Jun;13(6):1116-9
pubmed: 19238493
Am J Gastroenterol. 2009 Dec;104(12):2973-86
pubmed: 19755971
Clin Gastroenterol Hepatol. 2011 Feb;9(2):130-6
pubmed: 21056696
Expert Rev Gastroenterol Hepatol. 2015 Jun;9(6):797-806
pubmed: 25816833
J Crohns Colitis. 2017 Feb;11(2):135-149
pubmed: 27660342
J Clin Gastroenterol. 1995 Jan;20(1):27-32
pubmed: 7884173

Auteurs

Jacek Hermann (J)

Department of General and Endocrinological Surgery, and Gastroenterological Oncology, Poznan University of Medical Sciences, Poznan, Poland.

Piotr Stajgis (P)

Department of Radiology, Poznan University of Medical Sciences, Poznan, Poland.

Barbara Kołodziejczak (B)

Department of Computer Science and Statistics, Poznan University of Medical Sciences, Poznan, Poland.

Piotr Eder (P)

Department of Gastroenterology, Human Nutrition, and Internal Medicine, Poznan University of Medical Sciences, Poznan, Poland.

Tomasz Banasiewicz (T)

Department of General and Endocrinological Surgery, and Gastroenterological Oncology, Poznan University of Medical Sciences, Poznan, Poland.

Classifications MeSH